Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination

Vaccine

Volumn 30, Issue 27, 2012, Pages 4073-4078

  Song, Ning ^a   Gao, Zhanhai ^a   Wood, James G ^a   Hueston, Linda ^b   Gilbert, Gwendolyn L ^b   MacIntyre, C Raina ^a   Quinn, Helen E ^c   Menzies, Robert ^c   McIntyre, Peter ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Australia; Congenital rubella syndrome; Rubella; Seroepidemiologic studies

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; CONGENITAL RUBELLA SYNDROME; DISEASE CONTROL; ENZYME IMMUNOASSAY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RUBELLA; SCHOOL CHILD; SEROLOGY; SEX DIFFERENCE; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; AUSTRALIA; BASIC REPRODUCTION NUMBER; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; DISEASE NOTIFICATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; RUBELLA; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84861526239     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.025     Document Type: Article

References (26)

1. CDC Rubella. Epidemiology and prevention of vaccine-preventable disease 2006, Public Health Foundation, Washington, DC. 9th ed. W. Atkinson (Ed.).
2. Plotkin S., Reef S. Rubella vaccine. Vaccines 2004, 707-743. WB Saunders Co., London. 4th ed. S. Plotkin, W. Orenstein (Eds.).
3. Menser M.A., Hudson J.R., Murphy A.M., Upfold L.J. Epidemiology of congenital rubella and results of rubella vaccination in Australia. Reviews of Infectious Diseases 1985, 7(March-April (Suppl. 1)):S37-S41.
4. Gidding H.F., Burgess M.A., Kempe A.E. A short history of vaccination in Australia. Medical Journal of Australia 2001, 174:37-40.
5. Gilbert G.L., Escott R.G., Gidding H.F., Turnbull F.M., Heath T.C., McIntyre P.B., et al. Impact of the Australian measles control campaign on immunity to measles and rubella. Epidemiology & Infection 2001, 127:297-303.
6. Immunization Guidelines 1989, South Australian Health Commission.
7. AustralianGovernment. Notifications for all diseases by State & Territory and year; 2012, March 19. Available: . http://www9.health.gov.au/cda/Source/Rpt_2_sel.cfm.
8. Heywood A.E., Gidding H.F., Riddell M.A., McIntyre P.B., MacIntyre C.R., Kelly H.A. Elimination of endemic measles transmission in Australia. Bulletin of the World Health Organisation 2009, 87:64-71.
9. WHO The immunological basis for immunisation series module 11: rubella 2008, W.H. Organisation.
10. Hull B., Dey A., Mahajan D., Menzies R., McIntyre PB Immunisation coverage annual report 2009. Communicable Diseases Intelligence 2011, 35(June):132-148.
11. Edmunds W.J., van de Heijden O.G., Eerola M., Gay N.J. Modelling rubella in Europe. Epidemiology & Infection 2000, 125:617-634.
12. Hull B., Deeks S., Menzies R., McIntyre P.B. Immunisation coverage annual report, 2007. Communicable Disease Intelligence 2009, 33:170-187.
13. Forrest J.M., Burgess M.A., Donovan T. A resurgence of congenital rubella in Australia?. Communicable Diseases Intelligence 2003, 27:533-536.
14. APSU, APSU Biannual Research Report, 2007-2008.
15. Gidding H.F., Young M., Pugh R., Burgess M. Rubella in Australia: can we explain two recent cases of congenital rubella syndrome?. Communicable Diseases Intelligence 2003, 27:537-540.
16. Serdula M.K., Halstead S.B., Wiebenga N.H., Herrmann K.L. Serological response to rubella revaccination. JAMA 1984, 251(April):1974-1977.
17. LeBaron C.W., Forghani B., Matter L., Reef S.E., Beck C., Bi D., et al. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. Journal of Infectious Diseases 2009, 200:888-899.
18. Davidkin I., Jokinen S., Broman M., Leinikki P., Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Journal of Infectious Diseases 2008, 197:950-956.
19. Miller E. Rubella reinfection. Archives of Disease in Childhood 1990, 65:820-821.
20. Hethcote H. Measles and rubella in the United States. American Journal of Epidemiology 1983, 117:2-13.
21. Nokes D.J., Anderson R.M., Anderson M.J. Rubella epidemiology in South East England. Journal of Hygiene 1986, 96:291-304.
22. Gidding H.F., Wood J., MacIntyre C.R., Kelly H., Lambert S.B., Gilbert G.L., et al. Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine 2007, 25:3574-3580.
23. CDC Elimination of rubella and congenital rubella syndrome-United States, 1969-2004. MMWR-Morbidity & Mortality Weekly Report 2005, 54:279-282.
24. Reef S. Rubella mass campaigns. Current Topics in Microbiology & Immunology 2006, 304:221-229.
25. Brotherton J., Wang H., Schaffer A., Quinn H., Menzies R., Hull B., et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence 2007, 31(Suppl.):S1-S152.
26. Anderson R., May R. Infectious diseases of humans 1991, Oxford University Press.